Fidelity Investments
OSTX

Fidelity Investments’s OS Therapies Inc OSTX Stock Holding History

Fidelity Investments’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$2 – 5738
2026
Q1 		$2 Buy
+2
New +$3 ﹤0.01% 5404

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments's OSTX Position: Q2 2026 in Review

Fidelity Investments sold out of OS Therapies Inc (OSTX) in Q2 2026, closing a stake of 2 shares — an estimated $2 sold.

Fidelity Investments first reported a position in OSTX in Q1 2026 and held it in 1 quarter. The position peaked at $2 in Q1 2026. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Fidelity Investments reported no remaining OS Therapies Inc position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 2 OS Therapies Inc shares in Q2 2026, an estimated $2.
  • Fidelity Investments first reported a position in OS Therapies Inc in Q1 2026 and held it in 1 quarter.
  • Fidelity Investments's OS Therapies Inc position peaked at $2 in Q1 2026.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.